COVID-19

Health Emergency Readiness Canada is tasked with boosting Canada’s life-sciences sector and ensuring Canadians get faster access to vaccines, medical therapies and diagnostics by accelerating the transition from research to commercialization.

The Pfizer-BioNTech mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant.

As techs we may not have the education of pharmacists, but we still have the same duty to protect our patients.

The protein-based vaccine, called Nuvaxovid, has been reformulated to target the JN.1 subvariant of Omicron.

Last year, 66% of 7- and 17-year-old students who had their records checked were overdue for vaccines to start the year.

The mRNA vaccine, called Spikevax, has been reformulated to target the KP.2 subvariant of Omicron.

With over 16,000 reported cases of physical and verbal assaults nationwide in 2023 alone, Italian doctors and nurses have called for drastic measures.

Most of us can agree that the time for closed borders and widespread lockdowns has passed. Some have claimed that though we are not ‘post-COVID,’ we are ‘post-crisis.’ But the question remains: ‘What should we be doing about COVID now?’